decreased by -6% as a focus on optimizing costs has shown good progress. On the variable cost side fuel costs were higher than in the same period last year and also in fixed costs related to production
installed in the past year. However, the main variable costs including raw materials and consumables used decreased from the previous year as the production slowed down. The only selling and administrative
synergies of the acquisition contributed to the growth in revenue while variable cost synergies (particularly on fuel specific consumption optimization) contributed positively to consolidated EBITDA
period ending 31 March 2018 could be divided in to two key components as follows: 1. Variable cost component which shall be varied in accordance with the volume sold consist of (1) raw materials and
sold of the Group for the 3-month period ending 30 June 2018 could be divided in to two key components as follows: 1. Variable cost component which shall be varied in accordance with the volume sold
compared to the previous quarter. Cost of goods sold of the Group for the 3-month period ending 30 June 2018 could be divided in to two key components as follows: 1. Variable cost component which shall be
Pharma Ltd. took effect as from September 1, 2018). Besides, some expense items decreased by a total of around Baht 14 .5 million in 2019, comprising sales promotion expense, cost of exhibition booth
, 2018). Besides, some expense items decreased by a total of around Baht 14 .5 million in 2019, comprising sales promotion expense, cost of exhibition booth display, cost of sample products, expense on